The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScancell Holdings Share News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.40
Bid: 9.00
Ask: 9.80
Change: 0.25 (2.73%)
Spread: 0.80 (8.889%)
Open: 9.15
High: 9.40
Low: 9.15
Prev. Close: 9.15
SCLP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Caerus, Bezant pick Cyprus asset; TomCo buys JV

Thu, 26th Aug 2021 12:53

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Caerus Mineral Resources PLC - copper and gold explorer with licenses in Cyprus - Alongside copper-gold exploration and development company Bezant Resources PLC, Caerus notes the Troulli project in Cyprus has been selected as the first project for a joint-venture. "The joint review, which will also have input from Jubilee Metals Group PLC, will cover all waste recycling and hard rock VMS projects within the Caerus portfolio with an emphasis on Troulli as the first joint venture project between Caerus and Bezant," Caerus explains. Says diamond drilling and resource estimate programme to be agreed at project.

----------

TomCo Energy PLC - oil project development in US focused on using new technology to unlock unconventional hydrocarbon resources - Buys Valkor LLC's 50% interest in the Greenfield Energy LLC joint-venture. TomCo now owns all of Greenfield. Will fund the acquisition through a deferred issue of 592.8 million shares, currently 29% of the company's capital.

----------

Power Metal Resources PLC - metal exploration and development in Africa - Says total of 19 holes completed at first phase of diamond drilling exploration programme at Silver Peak project in Canada. "All cores are being logged, catalogued and split by independent geological consultants prior to being sent to ALS Canada Ltd in Vancouver, British Columbia, for accredited laboratory assay analysis," Power Metal adds. Establishes new vehicle named Silver Peak Resources Ltd in anticipation of public listing of project, or to allow for a third party acquisition. At Tati in Botswana, crews have been mobilised for phase 2 work programme on the gold and nickel greenstone belt.

----------

Aura Energy Ltd - Australia-based minerals company - Completes gravity survey at Tasiast South tenements in Mauritania. "The gravity data allows better definition of geology, the identification of structures likely to be of relevance to gold deposition and the possibility of direct detection of sulphide mineralisation on the nickel/cobalt targets," Aura says.

----------

Westmount Energy Ltd - invests in companies which operate in oil & gas related industries - Notes beginning of drilling at Sapote-1, located in Canje block in offshore Guyana. Westmount holds a 7.2% interest in Canje, which is operated by Exxon Mobil Corp. Exxon's Esso Exploration & Production Guyana Ltd has a 35% stake, TotalEnergies SE unit TotalEnergies E&P Guyana BV also holds 35%.

----------

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Secures USD24 million supply and distribution pact with AMC Holdings Inc for its phytomedicine products. The deal lasts three years. "This is MGC Pharma's first USA supply agreement dedicated to taking MGC's pharmaceutical phytocannabinoid products into the world's largest healthcare market," company adds. For the first year, AMC will pay MGC USD750,000 and a letter of credit for a further USD2.3 million.

----------

Scancell Holdings PLC - Oxford, England-based immunotherapies for treatment of cancer and infectious disease - Says UK's Medicines & Healthcare Products Regulatory Authority approves plans to kick off first-in-human trial of Modi-1 vaccine which targets cancer cells. "The company expects to enrol patients into the study in the second half of 2021, following ethics committee sign-off. Initial safety and tolerability data from the initial open label portion of the trial could be available from the first half of 2022," Scancell says.

----------

Eden Research PLC - Cirencester-based agricultural chemicals producer - Says Mevalone biofungicide receives green light for use on new crops in Portugal. The product is used to treat Botrytis cinerea, a fungal pathogen. "This latest label extension adds strawberries, raspberries, blueberries, cranberries, kiwi, aubergines and peppers to the label, with product applications being permitted close to the point of harvest," Eden explains.

----------

Bidstack Group PLC - London-based in-game advertising platform - Partners with Motionlab Interactive, the makers of mobile game PDC Darts Match. PDC is the Professional Darts Corp, a darts governing body. "The new game expands Bidstack's stadium vertical and increases the number of sports covered to five different categories (football, tennis, cricket, jiu-jitsu and darts)," Bidstack explains.

----------

D4t4 Solutions PLC - Surrey-based data management company - Says continuing to trade in line with board expectation. "The business is delivering against its key KPIs and is well positioned in its core markets," D4t4 says. Says rolllout of Celebrus Fraud Data platform progresses. Company adds: "D4t4 has also commenced a marketing and PR campaign, particularly focused on raising the profile of Celebrus products in the US market."

----------

Braemar Shipping Services PLC - London-based shipbroker - "Pleased" by performance in first five months of financial year ended February. Braemar says: "Trading has been good across all three of the group's divisions and the breadth of the group's business model, the diversity of the broking operation and the markets in which the group now operates, have insulated the business well from any ongoing pandemic weakness."

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
22 Jul 2020 11:24

IN BRIEF: Scancell To Raise GBP15 Million Via Share, Loan Note Issue

IN BRIEF: Scancell To Raise GBP15 Million Via Share, Loan Note Issue

Read more
24 Jun 2020 12:18

Scancell To Start Clinical Trial For Cancer Treatment In 2021

Scancell To Start Clinical Trial For Cancer Treatment In 2021

Read more
12 Jun 2020 12:59

Scancell upbeat on publication of AvidiMab research

(Sharecast News) - Cancer immunotherapy developer Scancell Holdings noted the publication of its manuscript in Cancer Research, a journal of the American Association of Cancer Research (AACR) on Friday, titled 'Engineering the human Fc-region enables direct cell killing by cancer glycan-targeting antibodies without the need for immune effector cells or complement'.

Read more
28 Apr 2020 16:40

Director dealings: Scancell director lowers stake

(Sharecast News) - Scancell revealed on Tuesday that non-executive director Martin Diggle had sold 1.5m ordinary shares in the AIM-listed biotechnology firm.

Read more
28 Apr 2020 14:43

UK DIRECTOR DEALINGS SUMMARY: Citrus Buys More easyHotel At Exit Price

UK DIRECTOR DEALINGS SUMMARY: Citrus Buys More easyHotel At Exit Price

Read more
24 Apr 2020 12:00

Scancell Rises On Launch Of Covid-19 Vaccine Research Programme

Scancell Rises On Launch Of Covid-19 Vaccine Research Programme

Read more
24 Apr 2020 10:49

UK WINNERS & LOSERS SUMMARY: FirstGroup Rises On Liquidity Boost

UK WINNERS & LOSERS SUMMARY: FirstGroup Rises On Liquidity Boost

Read more
3 Feb 2020 14:20

Scancell's 'SCIB1' clears latest regulatory hurdle in US

(Sharecast News) - Cancer immunotherapy developer Scancell announced on Monday that its investigational new drug (IND) application to the United States Food and Drug Administration (FDA) for 'SCIB1' has been approved.

Read more
3 Feb 2020 10:44

Scancell Gets US FDA Approval For SCIB1 Drug Application

Scancell Gets US FDA Approval For SCIB1 Drug Application

Read more
31 Jan 2020 11:12

Scancell Interim Loss Narrows, Progresses On Product Pipeline

Scancell Interim Loss Narrows, Progresses On Product Pipeline

Read more
20 Jan 2020 12:04

Scancell Teams To Evaluate Its Antibody Platform For Cancer Treatment

Scancell Teams To Evaluate Its Antibody Platform For Cancer Treatment

Read more
18 Dec 2019 16:29

DIRECTOR DEALINGS: Scancell Non-Executive Diggle Buys 3 Million Shares

DIRECTOR DEALINGS: Scancell Non-Executive Diggle Buys 3 Million Shares

Read more
16 Dec 2019 13:30

Scancell inks AvidiMab agreement with Chinese biotech company

(Sharecast News) - Scancell Holdings on Monday signed a collaboration and non-exclusive research agreement with an unnamed Chinese biotechnology firm.

Read more
16 Dec 2019 09:21

Scancell Shares Jump As It Secures First Deal In China For AvidiMab

Scancell Shares Jump As It Secures First Deal In China For AvidiMab

Read more
12 Dec 2019 14:23

Oxford Technology VCTs Report Mixed Third-Quarter Performances

Oxford Technology VCTs Report Mixed Third-Quarter Performances

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.